The Health Ministry warns that patients should take GLP-1 drugs for type 2 diabetes and obesity only under medical supervision due to potential severe health complications and side effects. The government is enforcing regulatory measures to prevent misuse and unauthorized sales.
from mint - science https://ift.tt/ZUq1yDB
Wednesday, 1 April 2026
Using Ozempic-like shots? Govt issues urgent warning on GLP-1 drugs - 5 things to know
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment